Mark Lerman

580 total citations
18 papers, 388 citations indexed

About

Mark Lerman is a scholar working on Surgery, Transplantation and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark Lerman has authored 18 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 7 papers in Transplantation and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark Lerman's work include Renal Transplantation Outcomes and Treatments (7 papers), Transplantation: Methods and Outcomes (6 papers) and Renal and Vascular Pathologies (3 papers). Mark Lerman is often cited by papers focused on Renal Transplantation Outcomes and Treatments (7 papers), Transplantation: Methods and Outcomes (6 papers) and Renal and Vascular Pathologies (3 papers). Mark Lerman collaborates with scholars based in United States and Israel. Mark Lerman's co-authors include Michael J. Mack, Judson Hunt, Ron J. Anderson, Todd Dewey, Mitchell J. Magee, Morley A. Herbert, Michelle Lubetzky, Swati Rao, Janani Rangaswami and Peter A. McCullough and has published in prestigious journals such as Journal of the American Society of Nephrology, Journal of Pharmacology and Experimental Therapeutics and American Journal of Roentgenology.

In The Last Decade

Mark Lerman

18 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Lerman United States 10 178 171 78 59 51 18 388
Altair Jacob Mocelin Brazil 9 79 0.4× 130 0.8× 77 1.0× 83 1.4× 133 2.6× 33 454
Atul Mulay India 6 304 1.7× 161 0.9× 78 1.0× 64 1.1× 157 3.1× 10 438
Pranav Dalal United States 7 126 0.7× 95 0.6× 68 0.9× 31 0.5× 98 1.9× 14 307
Judson Hunt United States 12 142 0.8× 200 1.2× 120 1.5× 24 0.4× 197 3.9× 16 516
Ahmed A. Awan United States 8 95 0.5× 83 0.5× 55 0.7× 33 0.6× 69 1.4× 19 308
Jeroen Aalten Netherlands 7 241 1.4× 221 1.3× 138 1.8× 64 1.1× 129 2.5× 8 404
Fasika Tedla United States 10 137 0.8× 115 0.7× 88 1.1× 68 1.2× 104 2.0× 36 390
Josefina Santos Portugal 13 129 0.7× 162 0.9× 59 0.8× 92 1.6× 174 3.4× 46 478
Olaf Heisel Canada 6 253 1.4× 249 1.5× 35 0.4× 31 0.5× 54 1.1× 11 583
C.M. Kjellstrand United States 12 69 0.4× 123 0.7× 124 1.6× 59 1.0× 192 3.8× 40 448

Countries citing papers authored by Mark Lerman

Since Specialization
Citations

This map shows the geographic impact of Mark Lerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Lerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Lerman more than expected).

Fields of papers citing papers by Mark Lerman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Lerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Lerman. The network helps show where Mark Lerman may publish in the future.

Co-authorship network of co-authors of Mark Lerman

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Lerman. A scholar is included among the top collaborators of Mark Lerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Lerman. Mark Lerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Melancon, J. Keith, Ali Khalil, & Mark Lerman. (2020). Donor-Derived Cell Free DNA: Is It All the Same?. Kidney360. 1(10). 1118–1123. 21 indexed citations
2.
Wong, Rachel, et al.. (2020). Expanding Telehealth Competencies in Primary Care: A Longitudinal Interdisciplinary Simulation to Train Internal Medicine Residents in Complex Patient Care. Journal of Graduate Medical Education. 12(6). 745–752. 18 indexed citations
3.
Rangaswami, Janani, Roy O. Mathew, Ekamol Tantisattamo, et al.. (2019). Cardiovascular disease in the kidney transplant recipient: epidemiology, diagnosis and management strategies. Nephrology Dialysis Transplantation. 34(5). 760–773. 133 indexed citations
4.
Lerman, Mark, et al.. (2019). Post transplant renal vein thrombosis, with successful thrombectomy and review of the literature. International Journal of Surgery Case Reports. 61. 291–293. 7 indexed citations
5.
Nikaein, Afzal, et al.. (2018). Single center observation of the role of pre-existing HLA-DP antibodies in humoral rejection following renal transplantation. Transplant Immunology. 51. 58–61. 7 indexed citations
6.
Lerman, Mark, et al.. (2015). Bilateral native nephrectomy for refractory hypertension in kidney transplant and kidney pancreas transplant patients. International Journal of Surgery Case Reports. 15(C). 127–129. 9 indexed citations
7.
Nikaein, Afzal, et al.. (2008). CD30, a marker to detect the high‐risk kidney transplant recipients. Clinical Transplantation. 22(6). 765–769. 23 indexed citations
8.
Hunt, Judson, Mark Lerman, Mitchell J. Magee, et al.. (2005). Improvement of Renal Dysfunction by Conversion From Calcineurin Inhibitors to Sirolimus After Heart Transplantation. The Journal of Heart and Lung Transplantation. 24(11). 1863–1867. 62 indexed citations
9.
Hunt, Judson, Mark Lerman, Todd Dewey, Mitchell J. Magee, & Michael J. Mack. (2004). Conversion to sirolimus lessens renal dysfunction in heart transplant (HTX) patients. The Journal of Heart and Lung Transplantation. 23(2). S113–S113. 1 indexed citations
10.
Sahar, Gideon, Alon Stamler, Eldad Erez, et al.. (1999). Employment is a misleading indicator for successful outcome after heart transplantation. Transplantation Proceedings. 31(4). 1905–1906. 5 indexed citations
11.
Hootkins, Robert, et al.. (1990). Sequential and simultaneous "in series" hemodialysis and hemoperfusion in the management of theophylline intoxication.. Journal of the American Society of Nephrology. 1(6). 923–926. 13 indexed citations
12.
Hull, Alan R., Edward Warren, Da Long, et al.. (1982). Dialysis: A ten-year review. Seminars in Nephrology. 2(2). 90–98. 2 indexed citations
13.
Warren, Edward, Alan R. Hull, Da Long, et al.. (1982). Patient status in dialysis units. Seminars in Nephrology. 2(2). 186–188. 7 indexed citations
14.
Lerman, Mark, et al.. (1982). Continuous ambulatory peritoneal dialysis: Applications and longevity. Seminars in Nephrology. 2(2). 183–185. 1 indexed citations
15.
Anderson, Ron J., et al.. (1981). Clonidine overdose: Report of six cases and review of the literature. Annals of Emergency Medicine. 10(2). 107–112. 52 indexed citations
16.
Dickerman, Richard, et al.. (1978). New observations in renal transplants using ultrasound. American Journal of Roentgenology. 131(5). 851–855. 11 indexed citations
17.
Nechay, Bohdan R., R. Contreras, H Sarles, et al.. (1975). OUABAIN-SENSITIVE ADENOSINE TRIPHOSPHATASE FROM HUMAN KIDNEYS. Journal of Pharmacology and Experimental Therapeutics. 192(2). 303–309. 5 indexed citations
18.
Nechay, Bohdan R., R. Contreras, H Sarles, et al.. (1975). Ouabain-sensitive adenosine triphosphatase from human kidneys.. PubMed. 192(2). 303–9. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026